TNPSC Thervupettagam

Euvichol-S Cholera Vaccine

April 26 , 2024 212 days 483 0
  • The new inactivated oral vaccine Euvichol-S for cholera has received prequalification by the World Health Organisation (WHO).
  • There were 473,000 cholera cases reported to WHO in 2022, double the number from 2021.
  • Further increase of cases by 700,000 was estimated for 2023.
  • Currently, 23 countries are reporting cholera outbreaks with most severe impacts seen in the Comoros, Democratic Republic of the Congo, Ethiopia, Mozambique, Somalia, Zambia and Zimbabwe.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories